JPMorgan lowered the firm’s price target on XPeng to $8 from $9 and keeps a Neutral rating on the shares. The company’s Q2 results were broadly in line with little surprise although the Q3 delivery guidance is a moderate miss, the analyst tells investors in a research note. The firm believes the earnings report may not be enough to support a sustainable stock rebound.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on XPEV:
Questions or Comments about the article? Write to editor@tipranks.com